跳至主要内容
临床试验/JPRN-jRCTb042210159
JPRN-jRCTb042210159招募中1 期

Safety study of LR-PRP administration for intervertebral disc in low back pain patients with Modic type 1 change

Fujita Noboyuki0 个研究点目标入组 10 人开始时间: 2022年3月14日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 70age old(—)
性别
All

入选标准

  • 1 Has participated in the Informed Consent process and is willing and able to sign an informed consent
  • 2 aged 20 to 70 years old
  • 3 Visual Analogue Scale (VAS) pain intensity 50mm or more for more than 3 months due to low back pain caused by intervertebral disc degeneration
  • 4 Intervertebral disc degeneration with Modic type 1 change
  • 5 Willing and able to complete scheduled follow-up evaluations as described in the study protocol

排除标准

  • 1 BMI (Body Mass Index) : 30 or more
  • 2 Has a blood dyscrasia (platelet (Plt) less than 50,000 /microliter)
  • 3 Using anticoagulant or antiplatelet drug
  • 4 Has an autoimmune disease
  • 5 Has an active systemic inflammatory disease or infection
  • 6 Has a polyarthralgia
  • 7 Has an other spinal disease, including vertebral fracture
  • 8 Has a compromised host status (diabetic, immune deficiency, chronic renal failure, hepatic cirrhosis, using immunosuppressive drug etc.)
  • 9 Under treatment for malignant tumor
  • 10 Is known to be pregnant
  • 11 Judged as inappropriate subject by surgeons performing regenerative medicine

研究者

发起方
Fujita Noboyuki

相似试验